Sai Life Sciences Limited has informed the Exchange regarding Notice of Postal Ballot
SAILIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sai Life Sciences has issued a Postal Ballot Notice dated 15 May 2025 seeking shareholder approval through remote e-voting (18 May to 16 June 2025) for six resolutions. Four of these are special resolutions to ratify the ESOP 2008 Scheme (60,99,820 options) and Management ESOP 2018 Scheme (79,45,490 options), including extending their benefits to employees of subsidiary and group companies. These schemes were originally approved by members via EGM on 4 July 2024 prior to the company's IPO, and the ratification is required under SEBI's Share Based Employee Benefits Regulations. The remaining two resolutions cover the appointment of Dr. Dinesh V Patel as Independent Director for 5 years (24 March 2025 to 23 March 2030), with a commission of 1% of net profits capped at Rs. 35 lakh per annum, and Mr. Sivaramakrishnan Chittor as Whole-Time Director & CFO for 5 years. Results will be announced on or before 18 June 2025.
The resolutions are largely procedural/regulatory in nature: ratifying pre-IPO ESOP schemes for post-listing compliance and formalising director appointments already effective. The combined ESOP pool of approximately 1.40 crore options (against equity base post-IPO) represents potential future dilution, while the director appointments add new faces to the board without immediate material financial impact for shareholders.